Chemiluminescent detection of factor V Leiden in a routine laboratory

Annals of Clinical Biochemistry

Volumn 33, Issue 3, 1996, Pages 259-262

  Ballering, L A P ^a   Bon, M A M ^a   Steffens Nakken, H M ^a   Van Den Bergh, F A J T M ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Allele specific oligonucleotide hybridization; HLA B27; Polymerase chain reaction; Restriction analysis

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; ASSAY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; GENE MUTATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING;

EID: 0029888197     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329603300315     Document Type: Article

References (6)

1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7
2. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated Protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 4: 1031-5
3. Johnson AH, Hartzman RJ, Robinson MA. HLA: the major histocompatibility complex. In: Henry JB, ed. Clinical Diagnosis and Management By Laboratorv Methods. Philadelphia: WB Saunders, 1984; 790-805
4. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-6
5. Lindblad B, Svenson PJ, Dahlbäck B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994; 343: 917
6. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22